Yolanda Sanchez
Ex-GSK, Drug Discovery
Yolanda Sanchez has 25+ years of combined academic and industry experience in translational research and drug discovery. Yolanda’s expertise spans target and pathway identification and validation, lead optimization, candidate selection, translational studies, biomarkers, and early clinical studies. As a former Vice-President and Discovery Performance Unit head (Respiratory Therapy Area) at GSK, she was responsible for delivering a portfolio of novel mechanisms to address disease progression in chronic respiratory diseases. More recently, Yolanda has worked as an independent scientific consultant with over 10 biotech companies in various therapy areas (respiratory, renal, and skin diseases) and modalities (gene therapy, microbiome and synthetic biology, small molecule). Yolanda combines a deep understanding of the challenges and opportunities in the biotech space with her extensive scientific and executive experience in big pharma.